Publications by authors named "Kebede Hussein"

Claim this Profile
C
Chromosome 1 abnormalities in myeloid malignancies: a literature survey and karyotype-phenotype associations.
Domenica Caramazza, Kebede Hussein, Sergio Siragusa, Animesh Pardanani, Ryan A Knudson

Eur J Haematol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase1/-2 study of Pomalidomide in myelofibrosis.
Ruben A Mesa, Animesh D Pardanani, Kebede Hussein, Wenting Wu, Susan Schwager

Am J Hematol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Prognostic Scoring System-independent cytogenetic risk categorization in primary myelofibrosis.
Kebede Hussein, Animesh D Pardanani, Daniel L Van Dyke, Curtis A Hanson, Ayalew Tefferi

Blood· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytogenetic correlates of TET2 mutations in 199 patients with myeloproliferative neoplasms.
Kebede Hussein, Omar Abdel-Wahab, Terra L Lasho, Daniel L Van Dyke, Ross L Levine

Am J Hematol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis--prognostic relevance is independent of IPSS or karyotype.
Ayalew Tefferi, Sergio Siragusa, Kebede Hussein, Susan M Schwager, Curtis A Hanson

Am J Hematol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mature survival data for 176 patients younger than 60 years with primary myelofibrosis diagnosed between 1976 and 2005: evidence for survival gains in recent years.
Rakhee Vaidya, Sergio Siragusa, Jocelin Huang, Susan M Schwager, Curtis A Hanson, Kebede Hussein

Mayo Clin Proc· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis.
Ruben A Mesa, Susan Schwager, Deepti Radia, Andrea Cheville, Kebede Hussein

Leuk Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide-induced durable hematological and cytogenetic remission in del(5q)-associated de novo acute myeloid leukemia.
Kebede Hussein, Ayalew Tefferi

Leuk Res· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating blasts or myeloid precursor cells in peripheral blood can predict success of cytogenetic analysis.
Anne E Wiktor, Curtis A Hanson, Janice M Hodnefield, Kebede Hussein, Ayalew Tefferi

Leuk Res· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conventional cytogenetics in myelofibrosis: literature review and discussion.
Kebede Hussein, Daniel L Van Dyke, Ayalew Tefferi

Eur J Haematol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis-increased serum ferritin or transfusion load does not.
Ayalew Tefferi, Ruben A Mesa, Animesh Pardanani, Kebede Hussein, Susan Schwager

Am J Hematol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Karyotype complements the International Prognostic Scoring System for primary myelofibrosis.
Kebede Hussein, Jocelin Huang, Terra Lasho, Animesh Pardanani, Ruben A Mesa

Eur J Haematol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood cytogenetic studies in myelofibrosis: overall yield and comparison with bone marrow cytogenetic studies.
Kebede Hussein, Rhett P Ketterling, Gordon W Dewald, Daniel L Van Dyke, Ruben Mesa

Leuk Res· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia.
Kebede Hussein, Balkrishna Jahagirdar, Pankaj Gupta, Linda Burns, Karen Larsen

Am J Hematol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood cytogenetic studies in hematological neoplasms: predictors of obtaining metaphases for analysis.
Kebede Hussein, Rhett P Ketterling, Rachael L Hulshizer, Daniel G Kuffel, Anne E Wiktor

Eur J Haematol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK2V617F mutation screening as part of the hypercoagulable work-up in the absence of splanchnic venous thrombosis or overt myeloproliferative neoplasm: assessment of value in a series of 664 consecutive patients.
Animesh Pardanani, Terra L Lasho, Kebede Hussein, Susan M Schwager, Cristy M Finke

Mayo Clin Proc· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis